Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26016324 | 0.97 | GBA2 (0.37) | GBA2CYP2C19CES1 | |
| SCHEMBL26016323 | 0.97 | GBA2 (0.37) | GBA2CYP2C19CES1 | |
| SCHEMBL26016322 | 0.97 | GBA2 (0.37) | GBA2CYP2C19CES1 | |
| SCHEMBL25939791 | 0.93 | GBA2 (0.42) | GBA2CYP2C19CES1 | |
| SCHEMBL10287420 | 0.89 | GBA2 (0.34) | GBA2 | |
| SCHEMBL19420791 | 0.87 | HRH3 (0.41) | GBA2 | |
| SCHEMBL20314553 | 0.87 | GBA2 (0.33) | GBA2 | |
| SCHEMBL19420788 | 0.87 | HRH3 (0.41) | GBA2 | |
| SCHEMBL6377531 | 0.86 | CYP2C19 (0.38) | GBA2CYP2C19 | |
| SCHEMBL13817758 | 0.85 | HRH3 (0.39) | GBA2CYP2C19CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12384908-B2 | Multilayer polypropylene film for capacitor | PRIME POLYMER CO., LTD. (JP) | 2025-08-12 | — | — | US | disclosed |
| CN-115210833-B | Multilayer polypropylene film for capacitor | 普瑞曼聚合物株式会社 | 2024-08-13 | — | — | CN | disclosed |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | ARVINAS OPERATIONS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| EP-3647329-B1 | PROPYLENE-BASED POLYMER, METHOD FOR PREPARING SAME, PROPYLENE-BASED RESIN COMPOSITION, AND MOLDED BODY | MITSUI CHEMICALS INC (JP) | 2024-05-29 | — | — | EP | disclosed |
| US-11912699-B2 | Tau-protein targeting compounds and associated | ARVINAS OPERATIONS, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11858940-B2 | Selective modulators of mutant LRRK2 proteolysis and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-11707452-B2 | Modulators of alpha-synuclein proteolysis and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-20230088053-A1 | MULTILAYER POLYPROPYLENE FILM FOR CAPACITOR | PRIME POLYMER CO., LTD. (JP) | 2023-03-23 | — | — | US | disclosed |
| EP-4116997-A1 | MULTILAYER POLYPROPYLENE FILM FOR CAPACITOR | Prime Polymer Co., Ltd. (JP) | 2023-01-11 | — | — | EP | disclosed |
| CN-110662773-B | Propylene polymer, method for producing same, propylene resin composition, and molded article | 三井化学株式会社 | 2022-08-19 | — | — | CN | disclosed |
| EP-0362705-B1 | Catalysts for the polymerization of olefins | HIMONT INC (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5278210-A | Process for the preparation of stabilized polyolefins and products obtained therefrom | HIMONT INCORPORATED (US) | 1994-01-11 | — | — | US | disclosed |
| EP-0546573-A1 | Process for the preparation of stabilized polyolefins and products obtained therefrom | MONTELL NORTH AMERICA INC. (US) | 1993-06-16 | — | — | EP | disclosed |
| US-5122492-A | Magnesium dihalide, titanium halide or halogen alcoholate on porous metal oxide | HIMONT INCORPORATED (US) | 1992-06-16 | — | — | US | disclosed |
| EP-0452156-A2 | Solid titanium catalyst component for olefin polymerization, olefin polymerization catalyst, prepolymerized polyolefin-containing catalyst and method of olefin polymerization | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |
| EP-0434082-A2 | Components and catalysts for the polymerization of olefins | MONTELL NORTH AMERICA INC. (US) | 1991-06-26 | — | — | EP | disclosed |
| US-4978648-A | Alkyl-aluminum, diether, magnesium dichloride, titanium halide components; propylene polymerization | HIMONT INCORPORATED (US) | 1990-12-18 | — | — | US | disclosed |
| US-4971937-A | COORDINATION CATALYSTS OF TITANIUM HALIDES, MAGNESIUM HALIDES AND DI OR POLYETHER COMPOUNDS | HIMONT INCORPORATED (US) | 1990-11-20 | — | — | US | disclosed |
| EP-0362705-A2 | Catalysts for the polymerization of olefins | MONTELL NORTH AMERICA INC. (US) | 1990-04-11 | — | — | EP | disclosed |
| EP-0361494-A2 | Components and catalysts for the polymerization of olefins | MONTELL NORTH AMERICA INC. (US) | 1990-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912699-B2 | Tau-protein targeting compounds and associated | MAPT, VHL, CRBN | GBA2 3172/4885CYP2C19 4879/4885CES1 4218/4885 |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | IRAK1, IRAK4, IRAK2 | GBA2 4133/4885CYP2C19 4875/4885CES1 2784/4885 |
| US-11707452-B2 | Modulators of alpha-synuclein proteolysis and associated methods of use | UCHL1, ADRM1, CRBN | GBA2 784/4885CYP2C19 4865/4885CES1 3613/4885 |
| US-11858940-B2 | Selective modulators of mutant LRRK2 proteolysis and associated methods of use | LRRK2, ADRM1, CRBN | GBA2 824/4885CYP2C19 4846/4885CES1 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.